The influence of lymphoid reconstitution kinetics on clinical outcomes in allogeneic stem cell transplantation

References

• Birnbaum A. On the foundations of statistical inference. J Am Stat Assoc. 1962;57:269.
   Web of Science ®Google Scholar
• Biggs N. Discrete mathematics. London (UK): Oxford University Press; 2012.
   Google Scholar
• Laurin D, Hannani D, Pernollet M, et al. Immunomonitoring of graft–versus–host minor histocompatibility antigen correlates with graft–versus–host disease and absence of relapse after graft. Transfusion. 2010;50:418–428.
   PubMed Web of Science ®Google Scholar
• Morrrison F. The art of modeling dynamic systems: forecasting for chaos, randomness and determinism. Stochastic systems – pattern IV. Mineola (NY): Dover Publications; 2008. p. 278.
   Google Scholar
• Toor AA, Kobulnicky JD, Salman S, et al. Stem cell transplantation as a dynamical system: are clinical outcomes deterministic? Front Immunol. 2014;5:613.
   PubMed Web of Science ®Google Scholar
• Barrett J. Improving outcome of allogeneic stem cell transplantation by immunomodulation of the early post-transplant environment. Curr Opin Immunol. 2006;18:592–598.
   PubMed Web of Science ®Google Scholar
• Vandermeer JH, Goldberg DE. Population ecology: first principles. Woodstock (Oxfordshire): Princeton University Press; 2003. ISBN 0-691-11440-4.
   Google Scholar
• Stewart I. The imbalance of nature chaos theory. In: Pursuit of the unknown, 17 equations that changed the world. Philadelphia (PA): Basic Books; 2012. p. 283.
   Google Scholar
• May RM. Biological populations with nonoverlapping generations: stable points, stable cycles, and chaos. Science. 1974;186:645–647.
   PubMed Web of Science ®Google Scholar
• Savani BN, Mielke S, Rezvani K, et al. Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell–depleted allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2007;13:1216–1223.
   PubMed Web of Science ®Google Scholar
• Kawase T, Morishima Y, Matsuo K, et al. High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood. 2007;110:2235–2241.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Klein J, Haagenson M, et al. Highresolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110:4576–4583.
   PubMed Web of Science ®Google Scholar
• Kawase T, Matsuo K, Kashiwase K, et al. HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism. Blood. 2009;113:2851–2858.
   PubMed Web of Science ®Google Scholar
• Peric Z, Cahu X, Chevallier P, et al. Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation. Leukemia. 2011;25:932–938.
   PubMed Web of Science ®Google Scholar
• Deeg H, Storer B, Boeckh M, et al. Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen. Biol Blood Marrow Transplant. 2006;12:573–584.
   PubMed Web of Science ®Google Scholar
• Duggan P, Booth K, Chaudhry A, et al. Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis. Bone Marrow Transplant. 2002;30:681–686.
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, Lamparelli T, Barisione G, et al. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transplant. 2006;12:560–565.
   PubMed Web of Science ®Google Scholar
• Portier DA, Sabo RT, Roberts CH, et al. Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients. Bone Marrow Transplant. 2012;47:1513–1519.
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, Lamparelli T, Bruzzi P, et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood. 2001;98:2942–2947.
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, Ballen K, Rizzo D, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15:1628–1633.
   PubMed Web of Science ®Google Scholar
• Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol. 1997;97:855.
   PubMed Web of Science ®Google Scholar
• Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR Severity index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol. 1997;97:855.
   PubMed Web of Science ®Google Scholar
• Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204.
   Google Scholar
• Kim H, Armand P, Frederick D, et al. Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome. Biol Blood Marrow Transplant. 2015;21:873–880.
   PubMedGoogle Scholar
• Yamamoto W, Ogusa E, Matsumoto K, et al. Lymphocyte recovery on day 100 after allogeneic hematopoietic stem cell transplant predicts non-relapse mortality in patients with acute leukemia or myelodysplastic syndrome. Leuk Lymphoma. 2014;55:1113–1118.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Barrett AJ, Schaffer M, et al. Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies. Biol Blood Marrow Transplant. 2009;15:1108–1115.
   PubMed Web of Science ®Google Scholar
• Thoma MD, Huneke TJ, DeCook LJ, et al. Peripheral blood lymphocyte and monocyte recovery and survival in acute leukemia postmyeloablative allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant. 2012;18:600–607.
   PubMed Web of Science ®Google Scholar
• Pavletic ZS, Joshi SS, Pirruccello SJ, et al. Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant. 1998;21:33–41.
   PubMed Web of Science ®Google Scholar
• Kumar S, Chen MG, Gastineau DA, et al. Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplant. 2001;28:951–956.
   PubMed Web of Science ®Google Scholar
• Buhlmann L, Buser AS, Cantoni N, et al. Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT. Bone Marrow Transplant. 2010;46:1357–1362.
   PubMed Web of Science ®Google Scholar
• Kim HT, Frederick D, Andler E, et al. Prognostic signifcance of whiteblood cell counts on clinical outcome after allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2014;89:591–597.
   PubMed Web of Science ®Google Scholar
• Auletta JJ, Lazarus HM. Immune restoration following hematopoietic stem cell transplantation: an evolving target. Bone Marrow Transplant. 2005;35:835–857.
   PubMed Web of Science ®Google Scholar
• Peggs KS, Mackinnon S. Immune reconstitution following haematopoietic stem cell transplantation. Br J Haematol. 2004;124:407–420.
   PubMed Web of Science ®Google Scholar
• Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant. 1990;5:209–226.
   PubMed Web of Science ®Google Scholar
• Koparde V, Abdul Razzaq B, Suntum T, et al. Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: understanding randomness in alloreactivity incidence following stem cell transplantation. PLoS One. 2017;12:e0187771.
   PubMed Web of Science ®Google Scholar
• Abdul Razzaq B, Scalora A, Koparde V, et al. Dynamical system modeling to simulate donor T cell response to whole exome sequencing‐derived recipient peptides demonstrates different alloreactivity potential in HLA‐matched and -mismatched donor‐recipient pairs. Biol Blood Marrow Transplant. 2016;22:850–861.
   PubMed Web of Science ®Google Scholar